DIAGNOSTIC PATHOLOGY UPDATE 2021
USCAP is a transformative leader in pathology education, creating better pathologists with updates in relevant information requisite for their performance and professional growth. The Academy is sensitive to the personal and cultural needs of practicing pathologists by providing conferences that welcome them with their families to exotic destination venues at which they are enriched with new knowledge and unusual experiences. The 2021 Diagnostic Pathology Update course combines expert subspecialized, academic faculty with exposure to ocean and rain forests symbolic of the dichotomy that is Costa Rica. From zip-lining to surfing, this tropical paradise brings pathologists into contact with the cuisine, agriculture, art and geography of a unique country that values education as its primary core value. Costa Rica has eliminated its standing army to use the savings from defense to improve education, health care and a durable social safety net.
USCAP is changing not only how we learn, but where we learn by re-imagining the learning environment and continuously elevating the quality of content. Experience top educators. Refine cognitive skills. Hold coffee beans in your hand. Inhale vapor from raging waterfalls. Witness rainbows in the evanescent colors of iguana skins. Feel sunsets scalding your memory.
Course Director: Rhonda K. Yantiss, MD & Jason L. Hornick, MD, PhD
Challenges in Hematopathology
Distinguishing between reactive and neoplastic proliferations in blood, bone marrow, lymph nodes, spleen and extra-nodal hematopoietic tissues, as well as accurately classifying neoplasms once they are identified, are essential for appropriate patient care. Pathologists struggle with differentiating reactive from neoplastic conditions in these organs, as well as in properly classifying hematopoietic neoplasms once they are diagnosed. This highly respected expert faculty will provide a unique mentoring experience in an intimate study environment at USCAP’s Interactive Learning Center. They intend to cover diagnostic criteria for new entities in the 2016 WHO Classification of Hematopoietic and Lymphoid Neoplasms and provide useful morphologic clues and ancillary techniques to help you distinguish neoplastic and reactive conditions..
Course Location: Palm Springs, CA
Course Director: Daniel A. Arber, MD
Modern Approaches to Classification of Hematolymphoid Neoplasms
Accurate diagnosis in hematopathology relies heavily on the complex integration of data from clinical presentation, conventional microscopy, immunohistochemistry, flow cytometry, and molecular and cytogenetic analyses. Diagnosis is often complicated by the fact that clinically relevant disease subsets can share overlapping diagnostic features, and both baseline appreciation for disease spectrum and appropriate application/interpretation of ancillary testing is lacking. This gap can lead to real and immediate clinical consequences for therapeutic selection and overall patient management.
While in-house testing for the vast array of available diagnostic, prognostic and predictive markers is not possible in every setting or practice, awareness of their applicability and impact on patient care is the responsibility of both the pathologist and treating clinician. This is particularly true in an era when patients are increasingly knowledgeable about genomic and proteomic analyses and the studies are easily accessible. Approaching this target by strengthening baseline knowledge and skill in application empowers the pathologist as a consultant to the clinical care team. This superb faculty will synthesize and deliver this strategic philosophy in the context of intimate mentoring and personalized attention to detail.
Course Location: Palm Springs, CA
Course Directors: Olga K. Weinberg, MD and Yuri Fedoriw, MD